Literature DB >> 30473347

Pathogenicity differences between a newly emerged TW-like strain and a prevalent QX-like strain of infectious bronchitis virus.

Gang Xu1, Jinlong Cheng1, Shuhui Ma2, Wenfeng Jia1, Shihong Yan1, Guozhong Zhang3.   

Abstract

TW-like IBV isolates have appeared frequently in recent years in mainland China. In this study, we compared the TW-like IBV GD strain and the predominant QX-like SD strain in terms of serology and pathogenicity to 3-week-old specific-pathogen-free chickens. Both strains could cause severe respiratory distress and renal lesions, with a mortality rate were approximately 20%. Virus were continuously shed via the respiratory tract and cloaca. However, the infection pattern of the two isolates were different. The GD strain persisted for a longer duration and caused extensive damages to the tracheas and lungs. Moreover, chickens infected with the GD strain showed inefficient recovery of damaged cilia after infection. Our findings suggested that the newly emerged TW-like IBV GD strain showed obvious differences in pathogenicity, tissue tropism and replication efficiency compared with the QX-like IBV SD strain, with the TW-like GD strain showing stronger tropism to the respiratory tract and a longer duration of clinical signs.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Infectious bronchitis virus; Pathogenicity; Serotype; TW-like; Tissue tropism

Mesh:

Year:  2018        PMID: 30473347     DOI: 10.1016/j.vetmic.2018.10.019

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Role of Stress Granules in Suppressing Viral Replication by the Infectious Bronchitis Virus Endoribonuclease.

Authors:  Jing Zhao; Delan Feng; Ye Zhao; Min Huang; Xuehui Zhang; Guozhong Zhang
Journal:  J Virol       Date:  2022-05-31       Impact factor: 6.549

2.  Pathogenic characteristics of a QX-like infectious bronchitis virus strain SD in chickens exposed at different ages and protective efficacy of combining live homologous and heterologous vaccination.

Authors:  Lei Shao; Jing Zhao; Lihua Li; Xiuying Huang; Huiming Yang; Jinlong Cheng; Changqing Liu; Guozhong Zhang
Journal:  Vet Res       Date:  2020-07-08       Impact factor: 3.683

3.  Emerging lethal infectious bronchitis coronavirus variants with multiorgan tropism.

Authors:  Yao-Tsun Li; Ting-Chih Chen; Shu-Yi Lin; Masaji Mase; Shin Murakami; Taisuke Horimoto; Hui-Wen Chen
Journal:  Transbound Emerg Dis       Date:  2019-11-20       Impact factor: 5.005

4.  Identification of Novel T-Cell Epitopes on Infectious Bronchitis Virus N Protein and Development of a Multi-epitope Vaccine.

Authors:  Yifeng Qin; Kaihang Tu; Qingyuan Teng; Delan Feng; Ye Zhao; Guozhong Zhang
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

5.  Efficacy of commercial polyvalent avian infectious bronchitis vaccines against Chinese QX-like and TW-like strain via different vaccination strategies.

Authors:  Guanming Shao; Tong Chen; Keyu Feng; Qiqi Zhao; Xinheng Zhang; Hongxin Li; Wencheng Lin; Qingmei Xie
Journal:  Poult Sci       Date:  2020-07-24       Impact factor: 3.352

6.  Evaluation of the reproductive system development and egg-laying performance of hens infected with TW I-type infectious bronchitis virus.

Authors:  Xiaorong Zhang; Kai Liao; Shuqin Chen; Kun Yan; Xubin Du; Chengcheng Zhang; Mengjiao Guo; Yantao Wu
Journal:  Vet Res       Date:  2020-07-31       Impact factor: 3.683

7.  The S2 Subunit of QX-type Infectious Bronchitis Coronavirus Spike Protein Is an Essential Determinant of Neurotropism.

Authors:  Jinlong Cheng; Ye Zhao; Gang Xu; Keran Zhang; Wenfeng Jia; Yali Sun; Jing Zhao; Jia Xue; Yanxin Hu; Guozhong Zhang
Journal:  Viruses       Date:  2019-10-22       Impact factor: 5.048

8.  Replicase 1a gene plays a critical role in pathogenesis of avian coronavirus infectious bronchitis virus.

Authors:  Jing Zhao; Keran Zhang; Jinlong Cheng; Wenfeng Jia; Ye Zhao; Guozhong Zhang
Journal:  Virology       Date:  2020-08-20       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.